📰 Presentation Webcast News
Presentation Webcast News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Presentation Webcast. Real-time updates on events, politics, business and more.
November 17, 2023
Operator: Good day, and thank you for standing by. Welcome to the Borr Drilling Limited Third Quarter 2023 Results Presentation Webcast and Conference Call [Operator Instructions].
November 10, 2023
PRINCETON, N.J., Nov. 09, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood
November 9, 2023
Q3 2023 Product sales grew 20% to $7.8M versus $6.5M in Q3 2022. Q3 2023 Total revenue was approximately $8.8M. The pivotal STAR-T trial remains blinded with database lock nearing and initial data analysis completion expected before year-end.PRINCETON, N.J., Nov. 09, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorptio
August 18, 2023
Operator: Good day, and thank you for standing by. Welcome to the Borr Drilling Limited Second Quarter 2023 Results Presentation Webcast and Conference Call.
May 25, 2023
Operator: Good day and thank you for standing by. Welcome to the Borr Drilling Limited Q1 2023 Results Presentation Webcast and Conference Call.
February 24, 2023
/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...
November 28, 2022
Presentation Webcast on November 30, 2022, at 2:30 PM ETITHACA, NY / ACCESSWIRE / November 28, 2022 / Odyssey Semiconductor Technologies, Inc. (OTCQB:ODII), a semiconductor device company developing innovative
November 3, 2022
/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...
November 3, 2022
/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...
November 3, 2022
CytoSorbents expects to achieve first milestone of the U.S. pivotal STAR-T Trial this monthPRINCETON, N.J., Nov. 3, 2022 /PRNewswire/ -- CytoSorbe...